Extended Cure Time definition

Extended Cure Time means, in respect of any Collateral Call Trigger Event in respect of which Administrative Agent or any Lender has delivered a Collateral Call Notice to Borrower, 5:00 p.m. on the fifth (5th) succeeding Scheduled Trading Day after the date of the Cure Time.
Extended Cure Time has the meaning provided in Section 4.1(a).
Extended Cure Time means, in respect of any Collateral Call Trigger Event in respect of which Administrative Agent or any Lender has delivered a Collateral Call Notice to Borrowers, 5:00 p.m. on the fifth (5th) succeeding Scheduled Trading Day after the date of the Cure Time.

More Definitions of Extended Cure Time

Extended Cure Time means, (a) in respect of a Collateral Shortfall or Mandatory Prepayment Event as to which an RCF Certificate has been delivered to Administrative Agent on or prior to the applicable Cure Time for such Collateral Shortfall or Mandatory Prepayment Event, as the case may be, the earliest of (i) 3:00 p.m. on the third Business Day immediately following such Cure Time, (ii) the time at which Administrative Agent notifies Borrower that it has determined that there is a reasonable likelihood that any of the representations and warranties set forth in the RCF Certificate was incorrect or misleading in any material respect or that any Sponsor has not complied with any covenant applicable to it set forth in the RCF Certificate in any material respect and (iii) the time of receipt of notice by Administrative Agent from any Sponsor that such Sponsor has received notice or has any other reason to believe that the contemplated funding specified in the RCF Certificate will not be consummated by 3:00 p.m. on the third Business Day immediately following such Cure Time or (b) in respect of a Collateral Shortfall or Mandatory Prepayment Event as to which a Capital Call Confirmation Package has been delivered to Administrative Agent on or prior to the applicable Cure Time for such Collateral Shortfall or Mandatory Prepayment Event, as the case may be, the earliest of (i) 3:00 p.m. on the twelfth Business Day immediately following such Cure Time, (ii) the time at which Administrative Agent notifies Borrower that it has determined that there is a reasonable likelihood that any of the representations and warranties set forth in the Capital Call Confirmation Package was incorrect or misleading in any material respect or that any Sponsor has not complied with any covenant applicable to it set forth in the Capital Call Confirmation Package in any material respect and (iii) the time of receipt of notice by Administrative Agent from any Sponsor that such Sponsor has received notice or has any other reason to believe that any of such Sponsor’s limited partners will not satisfy its obligations with respect to the relevant capital calls.
Extended Cure Time has the meaning specified in the Additional Terms Letter.
Extended Cure Time has the meaning provided in SECTION 4.1(A).
Extended Cure Time. LTV Ratio” or “Relevant Cure Time,” or increase the LTV Initial Level, the LTV Maintenance Level, the LTV Margin Call Level, or the LTV Release Level (or, in each case, any defined term used therein);
Extended Cure Time means, in respect of any Collateral Call Trigger Event in respect of which Administrative Agent or any Lender has delivered a Collateral Call Notice to Borrowers, 5:00 p.m. on the fifth (5th) succeeding Scheduled Trading Day after the date of the Cure Time. “Facility” means the credit facility contemplated by this Agreement. “Facility LTV” means, at any time, the LTV Level calculated immediately after giving effect to the most recent Advance or prepayment. “Facility Adjustment Event” means any of the following: (i) (a) any subdivision, consolidation or reclassification of Shares of any Share Type or any free distribution or dividend of Shares in respect of Shares, by way of bonus, capitalization or similar issue, (b) any dividend or distribution of cash, securities, rights, warrants, assets or property by an Issuer to all or substantially all holders of Shares of such Issuer (whether as a result of a spin-off or other similar transaction or otherwise), other than an Ordinary Cash Dividend; (c) a repurchase by an Issuer or any Subsidiary thereof of Shares of such Issuer, whether the consideration is cash, securities or otherwise, (d) an event that results in any shareholder rights being distributed in respect of, or becoming separated from, Shares pursuant to a shareholder rights plan or similar transaction or arrangement, (e) a call by an Issuer in respect of Shares of such Issuer that are not fully paid or (f) any other event with a dilutive or concentrative effect on the

Related to Extended Cure Time

  • Equity Financing means the next sale (or series of related sales) by the Company of its Equity Securities to one or more third parties following the date of this instrument from which the Company receives gross proceeds of not less than $1,000,000 cash or cash equivalent (excluding the conversion of any instruments convertible into or exercisable or exchangeable for Capital Stock, such as SAFEs or convertible promissory notes) with the principal purpose of raising capital.

  • Equity Issuance means any issuance or sale by a Person of any Equity Interest in such Person and shall in any event include the issuance of any Equity Interest upon the conversion or exchange of any security constituting Indebtedness that is convertible or exchangeable, or is being converted or exchanged, for Equity Interests.

  • First Issue Date means the date on which the Issuer issues a Series of Covered Bonds for the first time pursuant to the Programme;

  • Rating Decline means a decrease in the rating of the Notes by either Xxxxx’x or S&P by one or more gradations (including gradations within Rating Categories as well as between Rating Categories). In determining whether the rating of the Notes has decreased by one or more gradations, gradations within Rating Categories, namely + or – for S&P, and 1, 2, and 3 for Xxxxx’x, will be taken into account; for example, in the case of S&P, a rating decline either from BB+ to BB or BB- to B+ will constitute a decrease of one gradation.

  • Consolidated Current Assets at any date, all amounts (other than cash and Cash Equivalents) that would, in conformity with GAAP, be set forth opposite the caption “total current assets” (or any like caption) on a consolidated balance sheet of the Borrower and its Subsidiaries at such date.

  • Cure Amount has the meaning assigned to such term in Section 7.02(a).

  • Consolidated Current Liabilities means, as at any date of determination, the consolidated current liabilities of the Borrower and its Restricted Subsidiaries that may property be classified as current liabilities in conformity with GAAP, excluding, without duplication, the current portion of any long-term Indebtedness.

  • Net Cash Proceeds with respect to any issuance or sale of Capital Stock, means the cash proceeds of such issuance or sale net of attorneys' fees, accountants' fees, underwriters' or placement agents' fees, discounts or commissions and brokerage, consultant and other fees actually incurred in connection with such issuance or sale and net of taxes paid or payable as a result thereof.

  • Cash Proceeds means proceeds that are money, checks, deposit accounts, or the like.